Table 3.
Cases (n=66) | ||
---|---|---|
Highest location of care | ||
Neonatal unit | 20 (30%) | |
Paediatric intensive care unit | 4 (6%) | |
Paediatric inpatient ward | 30 (45%) | |
Postnatal ward | 12 (18%) | |
Clinical care received for COVID-19 | ||
Invasive ventilation (endotracheal intubation)* | 3 (5%) | |
Non-invasive ventilation* | 10 (15%) | |
Supplemental oxygen* | 22 (33%) | |
High-frequency oscillatory ventilation | 0 | |
Nitric oxide | 0 | |
Extracorporeal membrane oxygenation | 0 | |
No respiratory support | 42 (64%) | |
Therapeutic hypothermia | 0 | |
Missing data | 2 (3%) | |
Treatments received at time of COVID-19 | ||
Antibiotics | 46 (70%) | |
Antivirals | 2 (3%) | |
Corticosteroids | 2 (3%) | |
Anti-arrhythmic treatment | 1 (2%)† | |
Immunoglobulin | 1 (2%) | |
Outcome | ||
Still admitted | 3 (5%) | |
Discharged home | 58 (88%) | |
With home oxygen | 0 | |
With home respiratory support | 0 | |
For palliative care | 0 | |
With community nursing | 2 (3%) | |
No additional support | 56 (85%) | |
Transferred to another hospital | 4 (6%) | |
Died | 1 (2%) | |
Missing data | 0 |
Data are n (%).
Some babies received multiple forms of respiratory support.
Administered for condition considered unrelated to COVID-19.